Dunhill Financial’s Quest Diagnostics DGX Stock Holding History

Dunhill Financial’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$42.8K	Sell	218 -45	-17%	-$8.74K	0.01%	335
2025 Q4	$45.6K	Buy	263 +3	+1%	+$546	0.01%	285
2025 Q3	$49.5K	Buy	260 +2	+0.8%	+$355	0.01%	260
2025 Q2	$46.5K	Sell	258 -17	-6%	-$2.95K	0.01%	248
2025 Q1	$46.6K	Sell	275 -2	-0.7%	-$329	0.02%	198
2024 Q4	$41.7K	Sell	277 -113	-29%	-$17.6K	0.02%	198
2024 Q3	$60.6K	Buy	390 +13	+3%	+$1.94K	0.03%	154
2024 Q2	$51.6K	Buy	377 +125	+50%	+$17.1K	0.03%	147
2024 Q1	$33.6K	Buy	252 +2	+0.8%	+$259	0.02%	139
2023 Q4	$34.4K	Buy	+250	New	+$32.9K	0.03%	122

Other funds holding DGX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Dunhill Financial's DGX Position: Q1 2026 in Review

Dunhill Financial reduced its Quest Diagnostics (DGX) stake by 17% in Q1 2026, selling an estimated $8.74K and leaving 218 shares worth $42.8K. The position accounts for 0.01% of the portfolio, ranked #335.

Dunhill Financial first reported a position in DGX in Q4 2023 and has held it in 10 quarters since. The position peaked at $60.6K in Q3 2024. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

Dunhill Financial held 218 shares of Quest Diagnostics worth $42.8K as of Q1 2026.
Dunhill Financial sold 45 Quest Diagnostics shares in Q1 2026, an estimated $8.74K.
Quest Diagnostics made up 0.01% of Dunhill Financial's portfolio in Q1 2026, its #335 holding.
Dunhill Financial first reported a position in Quest Diagnostics in Q4 2023 and has held it in 10 quarters since.
Dunhill Financial's Quest Diagnostics position peaked at $60.6K in Q3 2024.
1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Dunhill Financial's 13F filing for Q1 2026, filed 6 May 2026.